| Antigen: | BCR-ABL |
| Clone: | 4C12 |
| Subclass | IgG1 |
| Species Raised In: | Balb/c |
| Immunogen: | BCR-ABL peptide |
| Cross Reactivity: | Human |
| Applications: | |
| Growth Conditions: | DMEM + 5% FCS |
| Fusion Partner: | P3X63Ag8.653 |
| Relevance: | The BCR gene is involved in the 9:22 translocation that generates the Philadelphia chromosome both in chronic myeloid leukemia (CML) and in a proportion of cases of acute lymphocytic leukemia (ALL). A 5' bcr sequence becomes fused to an abl sequence (including tyrosine kinase domain sequences) from chromosome 9 and results in the production of a chimaeric BCR-ABL protein with enhanced kinase activity. These antibodies may be useful for studies of the oncogene and have potential diagnostic and prognostic applications. |
| References: | Dhut S et al. 1988. Oncogene 3(5):561-6. PMID: 3078961Read more |
© Cancer Research Technology 2012